Abed Khorasani, Cynthia M Gorski, Na-Teng Hung, Joel Hulsizer, Vivek Paul, Goran Tomic, Prashanth R Prakash, Sangsoo Park, Gang Seo, Ethan J Houskamp, Jessica Lanis, Megan Hunzeker, Erin King, Anya Chappel, Alix Jampol, Pooja Patel, Catherine Gallagher, Rachel Galant, Grace Rucker, Jungwha Lee, Richard L Harvey, Jinsook Roh, Marc W Slutzky
{"title":"Wearable Myoelectric Interface for Neurorehabilitation (MINT) to Recover Arm Activity After Stroke: A Randomized Controlled Trial.","authors":"Abed Khorasani, Cynthia M Gorski, Na-Teng Hung, Joel Hulsizer, Vivek Paul, Goran Tomic, Prashanth R Prakash, Sangsoo Park, Gang Seo, Ethan J Houskamp, Jessica Lanis, Megan Hunzeker, Erin King, Anya Chappel, Alix Jampol, Pooja Patel, Catherine Gallagher, Rachel Galant, Grace Rucker, Jungwha Lee, Richard L Harvey, Jinsook Roh, Marc W Slutzky","doi":"10.1177/15459683261454937","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Abnormal muscle co-activation impairs arm function after stroke. Home-based myoelectric interface for neurorehabilitation (MINT) was developed to reduce abnormal co-activation.</p><p><strong>Objective: </strong>Evaluate MINT feasibility and effects on arm activity in a single-blind, randomized, sham-controlled trial.</p><p><strong>Methods: </strong>Moderately-to-severely impaired chronic stroke survivors were randomized to 1 of 3 MINT groups (who played customized games requiring independent activation of 2 or 3 abnormally co-activating muscles) or a sham control group (using 1 muscle). Participants trained 90 minutes/day, 6 days/week, switching upper-arm muscle sets every 2 to 3 weeks. Feasibility was assessed using training time, repetitions, and motivation. The primary efficacy outcome was the change in Wolf Motor Function Test (WMFT) from baseline to week 6 in each MINT group compared to sham. Secondary outcomes included WMFT at week 10, WMFT subscores, Fugl-Meyer, Modified Ashworth, Motor Activity Log, reaching kinematics, co-activation, and lesion location effects.</p><p><strong>Results: </strong>Fifty-nine participants completed training (mean: 86 ± 21 minutes/day, 315 ± 85 repetitions/day). The 3-muscle group improved WMFT by 6.8 seconds at week 6 (95% confidence interval [2.1-11.6 seconds], <i>P</i> = .001); other groups did not. Combined MINT groups improved by 4.1 seconds ([1.4-6.8 seconds], <i>P</i> = .0008). In per-protocol analysis, the 3-muscle group improved significantly more than sham on WMFT (7.5 seconds; [0.1-14.9 seconds], <i>P</i> = .046), shoulder/elbow subscores, and kinematics. At week 10, all MINT groups improved significantly, unlike sham. Reduced co-activation correlated significantly with improved arm function and movement. Stroke involving the internal capsule negatively predicted MINT response. Other secondary outcomes showed no clinically important changes.</p><p><strong>Discussion: </strong>MINT conditioning is feasible, reduces co-activation, and improves arm movement and activity.</p><p><strong>Clinical trial registration: </strong>ClinicalTrials.gov (NCT03401762).</p>","PeriodicalId":94158,"journal":{"name":"Neurorehabilitation and neural repair","volume":" ","pages":"953-965"},"PeriodicalIF":3.7000,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13278386/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurorehabilitation and neural repair","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/15459683261454937","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/8 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Abnormal muscle co-activation impairs arm function after stroke. Home-based myoelectric interface for neurorehabilitation (MINT) was developed to reduce abnormal co-activation.
Objective: Evaluate MINT feasibility and effects on arm activity in a single-blind, randomized, sham-controlled trial.
Methods: Moderately-to-severely impaired chronic stroke survivors were randomized to 1 of 3 MINT groups (who played customized games requiring independent activation of 2 or 3 abnormally co-activating muscles) or a sham control group (using 1 muscle). Participants trained 90 minutes/day, 6 days/week, switching upper-arm muscle sets every 2 to 3 weeks. Feasibility was assessed using training time, repetitions, and motivation. The primary efficacy outcome was the change in Wolf Motor Function Test (WMFT) from baseline to week 6 in each MINT group compared to sham. Secondary outcomes included WMFT at week 10, WMFT subscores, Fugl-Meyer, Modified Ashworth, Motor Activity Log, reaching kinematics, co-activation, and lesion location effects.
Results: Fifty-nine participants completed training (mean: 86 ± 21 minutes/day, 315 ± 85 repetitions/day). The 3-muscle group improved WMFT by 6.8 seconds at week 6 (95% confidence interval [2.1-11.6 seconds], P = .001); other groups did not. Combined MINT groups improved by 4.1 seconds ([1.4-6.8 seconds], P = .0008). In per-protocol analysis, the 3-muscle group improved significantly more than sham on WMFT (7.5 seconds; [0.1-14.9 seconds], P = .046), shoulder/elbow subscores, and kinematics. At week 10, all MINT groups improved significantly, unlike sham. Reduced co-activation correlated significantly with improved arm function and movement. Stroke involving the internal capsule negatively predicted MINT response. Other secondary outcomes showed no clinically important changes.
Discussion: MINT conditioning is feasible, reduces co-activation, and improves arm movement and activity.